{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:34:35Z","timestamp":1791588875088,"version":"4.3.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA016056"],"award-info":[{"award-number":["P30CA016056"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA160688"],"award-info":[{"award-number":["R01CA160688"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA250412"],"award-info":[{"award-number":["R01CA250412"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA251545"],"award-info":[{"award-number":["R01CA251545"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK-057543"],"award-info":[{"award-number":["R01DK-057543"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK104893"],"award-info":[{"award-number":["R01DK104893"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EB029596"],"award-info":[{"award-number":["R01EB029596"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37CA248018"],"award-info":[{"award-number":["R37CA248018"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-19-1-0111"],"award-info":[{"award-number":["W81XWH-19-1-0111"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-19-1-0674"],"award-info":[{"award-number":["W81XWH-19-1-0674"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"name":"VA Merit Award","award":["I01BX004033"],"award-info":[{"award-number":["I01BX004033"]}]},{"name":"Research Career Scientist Award","award":["IK6BX004477"],"award-info":[{"award-number":["IK6BX004477"]}]},{"name":"VA ShEEP Grant","award":["1 IS1 BX004777"],"award-info":[{"award-number":["1 IS1 BX004777"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1245\/s10434-022-12806-4","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T22:03:13Z","timestamp":1668722593000},"page":"1630-1641","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Conjugated Bile Acids Accelerate Progression of Pancreatic Cancer Metastasis via S1PR2 Signaling in Cholestasis"],"prefix":"10.1245","volume":"30","author":[{"given":"Joy","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayo","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Hylemon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6435-4241","authenticated-orcid":false,"given":"Kazuaki","family":"Takabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"issue":"1","key":"12806_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330. https:\/\/doi.org\/10.3322\/caac.21590.","journal-title":"CA Cancer J Clin."},{"issue":"9791","key":"12806_CR2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","volume":"378","author":"A Vincent","year":"2011","unstructured":"Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet. 2011;378(9791):607\u201320. https:\/\/doi.org\/10.1016\/S0140-6736(10)62307-0.","journal-title":"Lancet."},{"issue":"4","key":"12806_CR3","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s11605-008-0618-4","volume":"13","author":"NA van der Gaag","year":"2009","unstructured":"van der Gaag NA, Kloek JJ, de Castro SM, Busch OR, van Gulik TM, Gouma DJ. Preoperative biliary drainage in patients with obstructive jaundice: history and current status. J Gastrointest Surg. 2009;13(4):814\u201320. https:\/\/doi.org\/10.1007\/s11605-008-0618-4.","journal-title":"J Gastrointest Surg."},{"issue":"4","key":"12806_CR4","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/hep.27592","volume":"61","author":"M Nagahashi","year":"2015","unstructured":"Nagahashi M, Takabe K, Liu R, et al. Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression. Hepatology. 2015;61(4):1216\u201326. https:\/\/doi.org\/10.1002\/hep.27592.","journal-title":"Hepatology."},{"issue":"7","key":"12806_CR5","doi-asserted-by":"publisher","first-page":"929","DOI":"10.4161\/auto.6732","volume":"4","author":"MA Park","year":"2008","unstructured":"Park MA, Zhang G, Norris J, et al. Regulation of autophagy by ceramide-CD95-PERK signaling. Autophagy. 2008;4(7):929\u201331. https:\/\/doi.org\/10.4161\/auto.6732.","journal-title":"Autophagy."},{"issue":"1","key":"12806_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/hep.24681","volume":"55","author":"E Studer","year":"2012","unstructured":"Studer E, Zhou X, Zhao R, et al. Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes. Hepatology. 2012;55(1):267\u201376. https:\/\/doi.org\/10.1002\/hep.24681.","journal-title":"Hepatology."},{"issue":"1","key":"12806_CR7","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1053\/j.gastro.2011.03.044","volume":"141","author":"H Yang","year":"2011","unstructured":"Yang H, Li TW, Peng J, et al. A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression. Gastroenterology. 2011;141(1):378\u201388. https:\/\/doi.org\/10.1053\/j.gastro.2011.03.044.","journal-title":"Gastroenterology."},{"issue":"1","key":"12806_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12885-019-5391-0","volume":"19","author":"PL Labib","year":"2019","unstructured":"Labib PL, Goodchild G, Pereira SP. Molecular pathogenesis of cholangiocarcinoma. BMC Cancer. 2019;19(1):185. https:\/\/doi.org\/10.1186\/s12885-019-5391-0.","journal-title":"BMC Cancer."},{"issue":"27","key":"12806_CR9","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.3748\/wjg.15.3329","volume":"15","author":"H Bernstein","year":"2009","unstructured":"Bernstein H, Bernstein C, Payne CM, Dvorak K. Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol. 2009;15(27):3329\u201340. https:\/\/doi.org\/10.3748\/wjg.15.3329.","journal-title":"World J Gastroenterol."},{"key":"12806_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1756-8722-4-41","volume":"4","author":"J Dai","year":"2011","unstructured":"Dai J, Wang H, Shi Y, Dong Y, Zhang Y, Wang J. Impact of bile acids on the growth of human cholangiocarcinoma via FXR. J Hematol Oncol. 2011;4:41. https:\/\/doi.org\/10.1186\/1756-8722-4-41.","journal-title":"J Hematol Oncol."},{"issue":"3","key":"12806_CR11","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/hep.27223","volume":"60","author":"L Maroni","year":"2014","unstructured":"Maroni L, Alpini G, Marzioni M. Cholangiocarcinoma development: the resurgence of bile acids. Hepatology. 2014;60(3):795\u20137. https:\/\/doi.org\/10.1002\/hep.27223.","journal-title":"Hepatology."},{"issue":"3","key":"12806_CR12","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/hep.27085","volume":"60","author":"R Liu","year":"2014","unstructured":"Liu R, Zhao R, Zhou X, et al. Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2. Hepatology. 2014;60(3):908\u201318. https:\/\/doi.org\/10.1002\/hep.27085.","journal-title":"Hepatology."},{"issue":"2","key":"12806_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1124\/pr.107.07113","volume":"60","author":"K Takabe","year":"2008","unstructured":"Takabe K, Paugh SW, Milstien S, Spiegel S. \u201cInside-out\u201d signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol Rev. 2008;60(2):181\u201395. https:\/\/doi.org\/10.1124\/pr.107.07113.","journal-title":"Pharmacol Rev."},{"issue":"9","key":"12806_CR14","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1194\/jlr.R046656","volume":"55","author":"K Takabe","year":"2014","unstructured":"Takabe K, Spiegel S. Export of sphingosine-1-phosphate and cancer progression. J Lipid Res. 2014;55(9):1839\u201346. https:\/\/doi.org\/10.1194\/jlr.R046656.","journal-title":"J Lipid Res."},{"issue":"6","key":"12806_CR15","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/j.1476-5381.2010.01118.x","volume":"162","author":"RA Sabbadini","year":"2011","unstructured":"Sabbadini RA. Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration. Br J Pharmacol. 2011;162(6):1225\u201338. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.01118.x.","journal-title":"Br J Pharmacol."},{"issue":"1","key":"12806_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ccr.2012.11.013","volume":"23","author":"J Liang","year":"2013","unstructured":"Liang J, Nagahashi M, Kim EY, et al. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. Cancer Cell. 2013;23(1):107\u201320. https:\/\/doi.org\/10.1016\/j.ccr.2012.11.013.","journal-title":"Cancer Cell."},{"issue":"3","key":"12806_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1089\/lrb.2012.0010","volume":"10","author":"T Aoyagi","year":"2012","unstructured":"Aoyagi T, Nagahashi M, Yamada A, Takabe K. The role of sphingosine-1-phosphate in breast cancer tumor-induced lymphangiogenesis. Lymphat Res Biol. 2012;10(3):97\u2013106. https:\/\/doi.org\/10.1089\/lrb.2012.0010.","journal-title":"Lymphat Res Biol."},{"key":"12806_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/biom3030408","author":"WC Huang","year":"2013","unstructured":"Huang WC, Nagahashi M, Terracina KP, Takabe K. Emerging role of sphingosine-1-phosphate in inflammation, cancer, and lymphangiogenesis. Biomolecules. 2013. https:\/\/doi.org\/10.3390\/biom3030408.","journal-title":"Biomolecules."},{"issue":"3","key":"12806_CR19","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1158\/0008-5472.CAN-11-2167","volume":"72","author":"M Nagahashi","year":"2012","unstructured":"Nagahashi M, Ramachandran S, Kim EY, et al. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. Cancer Res. 2012;72(3):726\u201335. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-2167.","journal-title":"Cancer Res."},{"issue":"2","key":"12806_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3978\/j.issn.2227-684X.2012.07.01","volume":"1","author":"K Takabe","year":"2012","unstructured":"Takabe K, Yamada A, Rashid OM, et al. Twofer anti-vascular therapy targeting sphingosine-1-phosphate for breast cancer. Gland Surg. 2012;1(2):80\u20133. https:\/\/doi.org\/10.3978\/j.issn.2227-684X.2012.07.01.","journal-title":"Gland Surg."},{"issue":"10","key":"12806_CR21","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1016\/j.ajpath.2014.06.023","volume":"184","author":"Y Bi","year":"2014","unstructured":"Bi Y, Li J, Ji B, et al. Sphingosine-1-phosphate mediates a reciprocal signaling pathway between stellate cells and cancer cells that promotes pancreatic cancer growth. Am J Pathol. 2014;184(10):2791\u2013802. https:\/\/doi.org\/10.1016\/j.ajpath.2014.06.023.","journal-title":"Am J Pathol."},{"issue":"9","key":"12806_CR22","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1194\/jlr.R069286","volume":"57","author":"M Nagahashi","year":"2016","unstructured":"Nagahashi M, Yuza K, Hirose Y, et al. The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases. J Lipid Res. 2016;57(9):1636\u201343. https:\/\/doi.org\/10.1194\/jlr.R069286.","journal-title":"J Lipid Res."},{"issue":"2","key":"12806_CR23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jss.2011.10.025","volume":"176","author":"EC Little","year":"2012","unstructured":"Little EC, Wang C, Watson PM, Watson DK, Cole DJ, Camp ER. Novel immunocompetent murine models representing advanced local and metastatic pancreatic cancer. J Surg Res. 2012;176(2):359\u201366. https:\/\/doi.org\/10.1016\/j.jss.2011.10.025.","journal-title":"J Surg Res."},{"issue":"17","key":"12806_CR24","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.1016\/j.bmc.2013.06.012","volume":"21","author":"H Satsu","year":"2013","unstructured":"Satsu H, Schaeffer MT, Guerrero M, et al. A sphingosine 1-phosphate receptor 2 selective allosteric agonist. Bioorg Med Chem. 2013;21(17):5373\u201382. https:\/\/doi.org\/10.1016\/j.bmc.2013.06.012.","journal-title":"Bioorg Med Chem."},{"issue":"4","key":"12806_CR25","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1227\/01.NEU.0000367452.37534.B1","volume":"66","author":"A Sun","year":"2010","unstructured":"Sun A, Hou L, Prugpichailers T, et al. Firefly luciferase-based dynamic bioluminescence imaging: a noninvasive technique to assess tumor angiogenesis. Neurosurgery. 2010;66(4):751\u20137. https:\/\/doi.org\/10.1227\/01.NEU.0000367452.37534.B1.","journal-title":"Neurosurgery."},{"issue":"1","key":"12806_CR26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jss.2016.07.020","volume":"206","author":"H Aoki","year":"2016","unstructured":"Aoki H, Aoki M, Yang J, et al. Murine model of long-term obstructive jaundice. J Surg Res. 2016;206(1):118\u201325. https:\/\/doi.org\/10.1016\/j.jss.2016.07.020.","journal-title":"J Surg Res."},{"issue":"2","key":"12806_CR27","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.jss.2016.05.034","volume":"205","author":"H Aoki","year":"2016","unstructured":"Aoki H, Aoki M, Katsuta E, et al. Host sphingosine kinase 1 worsens pancreatic cancer peritoneal carcinomatosis. J Surg Res. 2016;205(2):510\u20137. https:\/\/doi.org\/10.1016\/j.jss.2016.05.034.","journal-title":"J Surg Res."},{"issue":"52","key":"12806_CR28","doi-asserted-by":"publisher","first-page":"30988","DOI":"10.1074\/jbc.M115.668277","volume":"290","author":"R Liu","year":"2015","unstructured":"Liu R, Li X, Qiang X, et al. Taurocholate induces cyclooxygenase-2 expression via the sphingosine 1-phosphate receptor 2 in a human cholangiocarcinoma cell line. J Biol Chem. 2015;290(52):30988\u20131002. https:\/\/doi.org\/10.1074\/jbc.M115.668277.","journal-title":"J Biol Chem."},{"key":"12806_CR29","doi-asserted-by":"publisher","first-page":"103672","DOI":"10.1016\/j.etap.2021.103672","volume":"86","author":"Z Chen","year":"2021","unstructured":"Chen Z, Wu Y, Wang B, et al. Intrahepatic cholestasis induced by \u03b1-naphthylisothiocyanate can cause gut-liver axis disorders. Environ Toxicol Pharmacol. 2021;86:103672. https:\/\/doi.org\/10.1016\/j.etap.2021.103672.","journal-title":"Environ Toxicol Pharmacol."},{"issue":"3","key":"12806_CR30","doi-asserted-by":"publisher","first-page":"G349","DOI":"10.1152\/ajpgi.00124.2017","volume":"314","author":"NL Berntsen","year":"2018","unstructured":"Berntsen NL, Fosby B, Valestrand L, et al. Establishment of a surgical bile duct injection technique giving direct access to the bile ducts for studies of the murine biliary tree. Am J Physiol Gastrointest Liver Physiol. 2018;314(3):G349-g359. https:\/\/doi.org\/10.1152\/ajpgi.00124.2017.","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"issue":"2","key":"12806_CR31","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jss.2016.06.003","volume":"204","author":"E Katsuta","year":"2016","unstructured":"Katsuta E, DeMasi SC, Terracina KP, et al. Modified breast cancer model for preclinical immunotherapy studies. J Surg Res. 2016;204(2):467\u201374. https:\/\/doi.org\/10.1016\/j.jss.2016.06.003.","journal-title":"J Surg Res."},{"key":"12806_CR32","doi-asserted-by":"publisher","DOI":"10.3791\/57849","author":"E Katsuta","year":"2018","unstructured":"Katsuta E, Oshi M, Rashid OM, Takabe K. Generating a murine orthotopic metastatic breast cancer model and performing murine radical mastectomy. J Vis Exp. 2018. https:\/\/doi.org\/10.3791\/57849.","journal-title":"J Vis Exp."},{"key":"12806_CR33","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jss.2017.06.048","volume":"219","author":"E Katsuta","year":"2017","unstructured":"Katsuta E, Rashid OM, Takabe K. Murine breast cancer mastectomy model that predicts patient outcomes for drug development. J Surg Res. 2017;219:310\u20138. https:\/\/doi.org\/10.1016\/j.jss.2017.06.048.","journal-title":"J Surg Res."},{"issue":"4","key":"12806_CR34","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1007\/s13577-020-00380-4","volume":"33","author":"E Katsuta","year":"2020","unstructured":"Katsuta E, Rashid OM, Takabe K. Clinical relevance of tumor microenvironment: immune cells, vessels, and mouse models. Hum Cell. 2020;33(4):930\u20137. https:\/\/doi.org\/10.1007\/s13577-020-00380-4.","journal-title":"Hum Cell."},{"issue":"2","key":"12806_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10911-017-9378-7","volume":"22","author":"T Kawaguchi","year":"2017","unstructured":"Kawaguchi T, Foster BA, Young J, Takabe K. Current update of patient-derived xenograft model for translational breast cancer research. J Mammary Gland Biol Neoplasia. 2017;22(2):131\u20139. https:\/\/doi.org\/10.1007\/s10911-017-9378-7.","journal-title":"J Mammary Gland Biol Neoplasia."},{"issue":"1","key":"12806_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10911-020-09442-7","volume":"25","author":"M Okano","year":"2020","unstructured":"Okano M, Oshi M, Butash A, et al. Orthotopic implantation achieves better engraftment and faster growth than subcutaneous implantation in breast cancer patient-derived xenografts. J Mammary Gland Biol Neoplasia. 2020;25(1):27\u201336. https:\/\/doi.org\/10.1007\/s10911-020-09442-7.","journal-title":"J Mammary Gland Biol Neoplasia."},{"key":"12806_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020444","author":"M Oshi","year":"2020","unstructured":"Oshi M, Okano M, Maiti A, et al. Novel breast cancer brain metastasis patient-derived orthotopic xenograft model for preclinical studies. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12020444.","journal-title":"Cancers (Basel)."},{"issue":"3","key":"12806_CR38","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10549-014-3118-0","volume":"147","author":"OM Rashid","year":"2014","unstructured":"Rashid OM, Nagahashi M, Ramachandran S, et al. An improved syngeneic orthotopic murine model of human breast cancer progression. Breast Cancer Res Treat. 2014;147(3):501\u201312. https:\/\/doi.org\/10.1007\/s10549-014-3118-0.","journal-title":"Breast Cancer Res Treat."},{"issue":"4","key":"12806_CR39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3978\/j.issn.2072-1439.2013.06.17","volume":"5","author":"OM Rashid","year":"2013","unstructured":"Rashid OM, Nagahashi M, Ramachandran S, et al. Is tail vein injection a relevant breast cancer lung metastasis model? J Thorac Dis. 2013;5(4):385\u201392. https:\/\/doi.org\/10.3978\/j.issn.2072-1439.2013.06.17.","journal-title":"J Thorac Dis."},{"issue":"2","key":"12806_CR40","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1517\/17425255.2015.983073","volume":"11","author":"OM Rashid","year":"2015","unstructured":"Rashid OM, Takabe K. Animal models for exploring the pharmacokinetics of breast cancer therapies. Expert Opin Drug Metab Toxicol. 2015;11(2):221\u201330. https:\/\/doi.org\/10.1517\/17425255.2015.983073.","journal-title":"Expert Opin Drug Metab Toxicol."},{"issue":"1","key":"12806_CR41","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jss.2015.04.030","volume":"199","author":"KP Terracina","year":"2015","unstructured":"Terracina KP, Aoyagi T, Huang WC, et al. Development of a metastatic murine colon cancer model. J Surg Res. 2015;199(1):106\u201314. https:\/\/doi.org\/10.1016\/j.jss.2015.04.030.","journal-title":"J Surg Res."},{"key":"12806_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413367","author":"M Ikarashi","year":"2021","unstructured":"Ikarashi M, Tsuchida J, Nagahashi M, et al. Plasma sphingosine-1-phosphate levels are associated with progression of estrogen receptor-positive breast cancer. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222413367.","journal-title":"Int J Mol Sci."},{"issue":"5","key":"12806_CR43","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/hepr.13625","volume":"51","author":"K Miura","year":"2021","unstructured":"Miura K, Nagahashi M, Prasoon P, et al. Dysregulation of sphingolipid metabolic enzymes leads to high levels of sphingosine-1-phosphate and ceramide in human hepatocellular carcinoma. Hepatol Res. 2021;51(5):614\u201326. https:\/\/doi.org\/10.1111\/hepr.13625.","journal-title":"Hepatol Res."},{"issue":"12","key":"12806_CR44","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1111\/cas.13802","volume":"109","author":"M Nagahashi","year":"2018","unstructured":"Nagahashi M, Abe M, Sakimura K, Takabe K, Wakai T. The role of sphingosine-1-phosphate in inflammation and cancer progression. Cancer Sci. 2018;109(12):3671\u20138. https:\/\/doi.org\/10.1111\/cas.13802.","journal-title":"Cancer Sci."},{"key":"12806_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186708","author":"M Oshi","year":"2020","unstructured":"Oshi M, Newman S, Tokumaru Y, et al. Intra-tumoral angiogenesis is associated with inflammation, immune reaction and metastatic recurrence in breast cancer. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21186708.","journal-title":"Int J Mol Sci."},{"issue":"9","key":"12806_CR46","first-page":"4394","volume":"11","author":"V Satyananda","year":"2021","unstructured":"Satyananda V, Oshi M, Tokumaru Y, et al. Sphingosine 1-phosphate (S1P) produced by sphingosine kinase 1 (SphK1) and exported via ABCC1 is related to hepatocellular carcinoma (HCC) progression. Am J Cancer Res. 2021;11(9):4394\u2013407.","journal-title":"Am J Cancer Res."},{"key":"12806_CR47","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jss.2020.06.057","volume":"256","author":"J Tsuchida","year":"2020","unstructured":"Tsuchida J, Nagahashi M, Nakajima M, et al. Sphingosine kinase 1 is associated with immune cell-related gene expressions in human breast cancer. J Surg Res. 2020;256:645\u201356. https:\/\/doi.org\/10.1016\/j.jss.2020.06.057.","journal-title":"J Surg Res."},{"key":"12806_CR48","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12935-019-1014-8","volume":"19","author":"P Wang","year":"2019","unstructured":"Wang P, Yuan Y, Lin W, Zhong H, Xu K, Qi X. Roles of sphingosine-1-phosphate signaling in cancer. Cancer Cell Int. 2019;19:295. https:\/\/doi.org\/10.1186\/s12935-019-1014-8.","journal-title":"Cancer Cell Int."},{"key":"12806_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081898","author":"P Gupta","year":"2021","unstructured":"Gupta P, Taiyab A, Hussain A, Alajmi MF, Islam A, Hassan MI. Targeting the sphingosine kinase\/sphingosine-1-phosphate signaling axis in drug discovery for cancer therapy. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13081898.","journal-title":"Cancers (Basel)."},{"issue":"3","key":"12806_CR50","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ccr.2006.02.023","volume":"9","author":"B Visentin","year":"2006","unstructured":"Visentin B, Vekich JA, Sibbald BJ, et al. Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell. 2006;9(3):225\u201338. https:\/\/doi.org\/10.1016\/j.ccr.2006.02.023.","journal-title":"Cancer Cell."},{"key":"12806_CR51","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.abb.2018.02.009","volume":"643","author":"S Tong","year":"2018","unstructured":"Tong S, Chen SC, Xu KY, Fang B, Wang SH, Wang JJ. 14\u20133-3zeta promotes esophageal squamous cell carcinoma invasion by repressing S1PR2 protein expression through NF-kappaB signaling. Arch Biochem Biophys. 2018;643:7\u201313. https:\/\/doi.org\/10.1016\/j.abb.2018.02.009.","journal-title":"Arch Biochem Biophys."},{"issue":"4","key":"12806_CR52","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/cncr.30393","volume":"123","author":"SK Pal","year":"2017","unstructured":"Pal SK, Drabkin HA, Reeves JA, et al. A phase 2 study of the sphingosine-1-phosphate antibody sonepcizumab in patients with metastatic renal cell carcinoma. Cancer. 2017;123(4):576\u201382. https:\/\/doi.org\/10.1002\/cncr.30393.","journal-title":"Cancer."},{"issue":"6","key":"12806_CR53","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.29076","volume":"65","author":"Y Wang","year":"2017","unstructured":"Wang Y, Aoki H, Yang J, et al. The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice. Hepatology. 2017;65(6):2005\u201318. https:\/\/doi.org\/10.1002\/hep.29076.","journal-title":"Hepatology."},{"issue":"11","key":"12806_CR54","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nrd3248","volume":"9","author":"V Brinkmann","year":"2010","unstructured":"Brinkmann V, Billich A, Baumruker T, et al. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov. 2010;9(11):883\u201397. https:\/\/doi.org\/10.1038\/nrd3248.","journal-title":"Nat Rev Drug Discov."},{"issue":"6","key":"12806_CR55","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1097\/01.ju.0000064938.32318.91","volume":"169","author":"H Azuma","year":"2003","unstructured":"Azuma H, Takahara S, Horie S, Muto S, Otsuki Y, Katsuoka Y. Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment. J Urol. 2003;169(6):2372\u20137. https:\/\/doi.org\/10.1097\/01.ju.0000064938.32318.91.","journal-title":"J Urol."},{"issue":"1","key":"12806_CR56","doi-asserted-by":"publisher","first-page":"5600","DOI":"10.1038\/s41598-017-06047-9","volume":"7","author":"LY Bai","year":"2017","unstructured":"Bai LY, Chiu CF, Chiu SJ, Chu PC, Weng JR. FTY720 induces autophagy-associated apoptosis in human oral squamous carcinoma cells, in part, through a reactive oxygen species\/mcl-1-dependent mechanism. Sci Rep. 2017;7(1):5600. https:\/\/doi.org\/10.1038\/s41598-017-06047-9.","journal-title":"Sci Rep."},{"issue":"1","key":"12806_CR57","first-page":"9","volume":"7","author":"LB Lucas da Silva","year":"2008","unstructured":"Lucas da Silva LB, Ribeiro DA, Cury PM, Cordeiro JA, Bueno V. FTY treatment in experimentally urethane-induced lung tumors. J Exp Ther Oncol. 2008;7(1):9\u201315.","journal-title":"J Exp Ther Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12806-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12806-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12806-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T21:41:30Z","timestamp":1675892490000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12806-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["12806"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12806-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,17]]},"assertion":[{"value":"17 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no potential conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}